Platelet-related indices in patients with lung cancer with nivolumab

Nomura Shosaku; Yokoi Takashi; Kurata Takayasu

首页> 外文期刊>Platelets >Platelet-related indices in patients with lung cancer with nivolumab

【24h】

Platelet-related indices in patients with lung cancer with nivolumab

机译：肺癌患者肺癌患者的血小板诊断

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Platelets》 |2018年第2期|共2页
作者
Nomura Shosaku; Yokoi Takashi; Kurata Takayasu;
展开▼
作者单位

Kansai Med Univ Dept Internal Med 1 2-5-1 Shin Machi Hirakata Osaka 5731010 Japan;

Kansai Med Univ Dept Internal Med 1 2-5-1 Shin Machi Hirakata Osaka 5731010 Japan;

Kansai Med Univ Dept Internal Med 1 2-5-1 Shin Machi Hirakata Osaka 5731010 Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类基础医学;
关键词

相似文献

外文文献
中文文献
专利

1. Platelet-related indices in patients with lung cancer with nivolumab [J] . Nomura Shosaku, Yokoi Takashi, Kurata Takayasu Platelets . 2018,第2期

机译：肺癌患者肺癌患者的血小板诊断
2. Response to the treatment immediately before nivolumab monotherapy may predict clinical response to nivolumab in patients with non-small cell lung cancer [J] . Kobayashi Haruki, Omori Shota, Nakashima Kazuhisa, International journal of clinical oncology . 2017,第4期

机译：在Nivolumab单药治疗前立即对治疗的反应可以预测非小细胞肺癌患者对Nivolumab的临床反应
3. An open label randomized Phase III trial of nivolumab or nivolumab plus ipilimumab vs platinum doublet chemotherapy (PT-DC) in patients with chemotherapy-na?ve stage IV or recurrent non-small cell lung cancer (NSCLC) (CheckMate 227) [J] . Matthew Hellmann, Suresh Ramalingam, Martin Reck, Journal for ImmunoTherapy of Cancer . 2015,第S2期

机译：一项针对nivolumab初治IV期或复发性非小细胞肺癌（NSCLC）患者的nivolumab或nivolumab联合ipilimumab与铂类双重化疗（PT-DC）的开放标签随机III期试验（CheckMate 227）
4. Survival prediction of squamous cell head and neck cancer patients based on radiomic features selected from lung cancer patients using artificial neural network [C] . H. Kamezawa, H. Arimura, M. Soufi SPIE Medical Imaging Conference . 2018

机译：利用人工神经网络从肺癌患者的放射学特征中预测鳞状细胞癌的生存率
5. The cost effectiveness of screening for early stage lung cancer and the testing and treatment of molecular subgroups among non-small cell lung cancer patients in the province of ontario, canada [D] . Thao, Mallory. 2014

机译：加拿大安大略省非小细胞肺癌患者早期肺癌筛查的成本效益及分子亚群的检测和治疗
6. Dynamics of blood neutrophil‐related indices during nivolumab treatment may be associated with response to salvage chemotherapy for non‐small cell lung cancer: A hypothesis‐generating study [O] . Hiroshi Soda, Daiki Ogawara, Yuichi Fukuda, 2019

机译：一项假设生成研究表明Nivolumab治疗期间血液中性粒细胞相关指标的动态可能与对挽救性化疗的反应有关
7. An open label randomized Phase III trial of nivolumab or nivolumab plus ipilimumab vs platinum doublet chemotherapy (PT-DC) in patients with chemotherapy-naïve stage IV or recurrent non-small cell lung cancer (NSCLC) (CheckMate 227) [O] . Matthew Hellmann, Suresh Ramalingam, Martin Reck, 2015

机译：一项针对nvolumab或nivolumab联合ipilimumab与铂类双重化疗（PT-DC）的初治IV期或复发性非小细胞肺癌（NSCLC）患者的开放标签随机III期临床试验（CheckMate 227）

Platelet-related indices in patients with lung cancer with nivolumab

著录项

相似文献

相关主题

期刊订阅